Clinical Trials on Otorhinolaryngologic Diseases

Total 381136 results

Shanghai Jiao Tong University School of Medicine
Fudan University; Tongji University; Second Military Medical University

Completed

Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Oral Cancer | Locally Advanced Malignant Neoplasm | Oropharyngeal Carcinoma

China
The University of Hong Kong

Unknown

Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Hong Kong
The Third Xiangya Hospital of Central South University

Completed

Intestinal Flora Sequencing for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Children

China
Fuzhou General Hospital

Unknown

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

Nasopharyngeal Carcinoma

China
Fudan University
The First Affiliated Hospital of Xiamen University; Fujian Province Tumor Hospital

Completed

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Peking University; Zhejiang Cancer Hospital; Fudan University; West China Hospital and other collaborators

Unknown

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) (NATELLA)

Nasopharyngeal Carcinoma

United States
Sun Yat-sen University
The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou... and other collaborators

Completed

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center
Fudan University; West China Hospital; Tongji Hospital; Peking University Cancer... and other collaborators

Unknown

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China, Taiwan, Singapore
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
The First Affiliated Hospital of Guangzhou Medical University; Affiliated Cancer... and other collaborators

Unknown

Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Rabin Medical Center

Unknown

Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Israel
Corporacion Parc Tauli

Completed

Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli

Nasopharyngeal Carcinoma

Spain
Taichung Veterans General Hospital
Fujian Cancer Hospital

Unknown

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.; Shin Nippon Biomedical Laboratories, Ltd.

Terminated

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Nasopharyngeal Carcinoma

Singapore
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Nasopharyngeal Carcinoma
Feng Jing

Unknown

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Guangdong Provincial People's Hospital; Affiliated Cancer Hospital of Shantou... and other collaborators

Unknown

A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Zhejiang Cancer Hospital; Fudan University; West China Hospital; Peking University... and other collaborators

Unknown

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Capital Medical University

Unknown

Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Zhejiang Cancer Hospital; Wenzhou Medical University; Xijing Hospital; Wuhan University and other collaborators

Completed

Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma (REPLACE)

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Zhejiang Cancer Hospital; Fudan University; Peking University Cancer Hospital... and other collaborators

Unknown

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
Daping Hospital and the Research Institute of Surgery...

Unknown

Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Fudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaborators

Completed

Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy (ENCORE)

Nasopharyngeal Carcinoma

China
Fudan University

Unknown

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Nasopharyngeal Carcinoma

China
Kousai Bio Co., Ltd.

Recruiting

KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Nasopharyngeal Carcinoma

China
National Cancer Centre, Singapore
Tan Tock Seng Hospital; BeiGene

Not yet recruiting

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Singapore
Zhejiang Cancer Hospital

Recruiting

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Hunan Cancer... and other collaborators

Recruiting

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fudan University

Recruiting

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC

Nasopharyngeal Carcinoma

China
Eye & ENT Hospital of Fudan University
The First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaborators

Recruiting

Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Nasopharyngeal Carcinoma

China
Wei Jiang
Wuzhou Red Cross Hospital; Laibin People's Hospital; Lingshan people's Hospital; Nanxishan Hospital of Guangxi Zhuang Autonomous Region and other collaborators

Recruiting

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Not yet recruiting

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Nasopharyngeal Carcinoma
National Cancer Centre, Singapore

Recruiting

Treatment Individualisation by EBV Stratification in Nasopharyngeal Carcinoma: a Prospective Observational Study

Nasopharyngeal Carcinoma

Singapore
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Chongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaborators

Recruiting

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
The First Hospital of Nanchang

Not yet recruiting

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guangxi Medical University

Not yet recruiting

Hearing Toxicity of Nasopharyngeal Carcinoma After Chemoradiotherapy

Nasopharyngeal Carcinoma
Jun-Lin Yi, MD

Recruiting

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital
Ningbo Medical Center Lihuili Hospital; Renmin Hospital of Wuhan University; First... and other collaborators

Recruiting

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Wei Jiang
Wuzhou Red Cross Hospital; Guangxi Nanxishan Hospital; Laibin People's Hospital; Lingshan people's Hospital

Recruiting

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Guangdong Provincial People's Hospital; Affiliated Cancer Hospital & Institute... and other collaborators

Recruiting

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Clinical Trials on Otorhinolaryngologic Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations